Toggle Mobile Navigation

Brochure Available! 2019 Drug Pricing and Reimbursement Stakeholder Summit

I invite you to view the brochure for the 2019 Drug Pricing and Reimbursement Stakeholder Summit, taking place on July 15–16 in Philadelphia!

With unpredictable changes occurring in the drug pricing transparency landscape, it is imperative to stay ahead of legislation and trends, thus maintaining a competitive edge within the industry.

Through panels, case studies, and focused presentations, this conference will showcase how key stakeholders surrounding drug pricing matters are initiating change to accommodate for drug pricing shifts.

Download the Brochure!

FEATURED SESSIONS

EXPLORE CHANGES TO THE POLICY LANDSCAPE THROUGH AN OVERVIEW OF THE MOST PREVALENT STATE TRANSPARENCY LAWS
Kendra MartelloSenior Director, Public PolicyMALLINCKRODT PHARMACEUTICALS

EXPLORE THE OPERATIONAL COMPONENT OF THE DRUG PRICING TRANSPARENCY LAWS AND DISCUSS ITS IMPLICATIONS ON DEPARTMENTAL PROCEDURES
Deborah WaltersVice President and Assistant General CounselPFIZER
Keren TenenbaumAssistant General CounselPFIZER

HARNESS VALUE-BASED AGREEMENT POWER FOR MAXIMUM MULTI-STAKEHOLDER BENEFIT
John AlterVP, Patient and Health Impact Lead, Hospital Business UnitPFIZER

THE EFFECT OF STRATEGIC PRACTICES WITHIN HEOR UPON VALUE-BASED PRICING AND REIMBURSEMENT MATTERS
Boxiong Tang, M.D.Senior Director, Health Economics and Outcomes Research (HEOR)BEIGENE, LTD.

Click here to reserve your seat today, or book before June 7 to save $200 off the standard registration rate.

 

posted in ExL Events News

live chat software